Most U.S. Infants Lack Measles Immunity by Six Months

A new study indicates maternal antibodies drop rapidly, leaving infants vulnerable before their first scheduled vaccine dose.

Updated on Oct. 23, 2026 in Babies

Most U.S. Infants Lack Measles Immunity by Six Months

Live Poll

Is it time to shift the first measles vaccine dose to an earlier age for infants?

A retrospective analysis reveals that most U.S. infants lose maternal measles antibodies by six months of age. Researchers suggest that this earlier-than-expected decline necessitates an evaluation of the timing for the first measles vaccination.

Why it matters

Understanding the duration of maternal protection is crucial for protecting vulnerable infants before they reach the standard age for their initial measles vaccine. This timing is particularly significant as measles cases continue to rise across the United States.

At six months of age, fewer than 20% of infants remain seropositive for specific measles strains. Antibody protection persists for approximately 6 months in infants born to mothers born before 1967, compared to just 4 months for those born to younger mothers.

The players

Centers for Disease Control and Prevention

This federal agency is the national public health institute of the United States and serves as the primary body for tracking infectious disease outbreaks.

Vanderbilt University

This research institution located in Nashville, Tennessee, conducted the analysis using samples from the MOMI-Vax and Mix & Match studies.

The details

The study analyzed serum samples from the MOMI-Vax and Mix & Match studies to determine how long infants retain maternal measles antibodies. Findings indicate that neutralizing antibody levels consistently fall below the necessary 120 mIU/mL threshold by the time an infant reaches two months of age.

1967: The U.S. measles eradication program was launched.
2025: A total of 2,289 measles cases were reported nationwide.
October 22, 2026: The CDC reported 4,588 total measles cases in the U.S.
October 23, 2026: The findings regarding maternal antibody decline were published.

Culture Shift

This research marks a significant departure from historical assumptions regarding the duration of maternal measles immunity. It suggests that the current U.S. measles eradication program may need to adjust vaccine scheduling to account for the shorter protective window seen in infants today.

Parents should consult with pediatricians regarding the latest vaccine schedules and local measles activity reports. Understanding that maternal protection wanes by six months helps families plan for timely immunization and maintain awareness of potential exposures.

The takeaway

Measles protection for infants is shorter than many caregivers assume, emphasizing the importance of staying current with CDC vaccination guidelines. Families in areas with active measles outbreaks should speak with their healthcare providers to discuss the best timing for initial protection.